Historical record - last NADAC effective date: 8/23/2023
Product Information
AMLODIPINE-ATORVAST 10-80 MG is a generic product labeled by Dr. Reddy's Laboratories Inc., priced at $3.2441 per EA under NDC 43598031330. Its NADAC has been published 443 times since May 14, 2014.
FDA first approved this application on Mar 7, 2014. Its Orange Book therapeutic-equivalence code is AB — FDA rates it therapeutically equivalent to (substitutable for) its reference product.
Strength
10; 80 mg/1; mg/1
Manufacturer
Dr. Reddy's Laboratories Inc.NDC
43598031330
Classification
Generic
Dosage Form
TABLET, FILM COATED
Route
ORAL
Effective Date
8/23/2023
Active Ingredients
AMLODIPINE BESYLATE; ATORVASTATIN CALCIUM TRIHYDRATEApproval Type
Generic (ANDA)
FDA Application
ANDA203874FDA Approved
3/7/2014
TE Code
AB
On Market Since
3/17/2014
Pharmacological Classes
Price Statistics
The NADAC for AMLODIPINE-ATORVAST 10-80 MG has been published 443 times since May 14, 2014, and over the history we have for it it has declined 49.2%. The table below summarizes its recorded NADAC range and movement.
| Current price | $3.2441 per EA |
|---|---|
| All-time high | $6.9697 (Mar 11, 2015) |
| All-time low | $3.2441 (Aug 23, 2023) |
| Median price | $4.1582 |
| Average price | $4.4666 |
| Largest weekly change | +64.1% (Aug 23, 2017) |
| Weeks tracked | 443 |
| Tracking since | May 14, 2014 |
1W
N/A
1M
N/A
3M
N/A
6M
N/A
1Y
N/A
3Y
0.0%
5Y
-14.9%
All
-49.2%
Last surveyed Nov 29, 2023 — this NDC no longer appears in the current weekly NADAC file.
Generic Alternatives
No other NADAC-published product shares this drug's active ingredient and strength in a comparable dosage form. Compare the broader picture on the Amlodipine besylate and Atorvastatin calcium market page.
Lowest-Cost Alternatives
No alternatives available
Related Drugs
Same classification
Continue researching this drug
Use these direct paths to move from a single NDC into the surrounding market, manufacturer, class, and trend context.
Manufacturer
Dr. Reddy's Laboratories Inc. manufacturer profile
See the full portfolio, pricing trend, and other products from this labeler.
Drug market
Amlodipine besylate and Atorvastatin calcium market comparison
Compare this molecule across participating manufacturers and inspect the broader market price spread.
Therapeutic class
Dihydropyridine Calcium Channel Blocker class view
See how this drug behaves alongside other products in the same FDA pharmacologic class.
Trend hub
Latest market trends
Zoom back out to the weekly mover view and compare this NDC with the rest of the current NADAC release.
Guide
Understanding NADAC pricing
Use the explainer when you need context on how CMS publishes NADAC and how to interpret the number on this page.
Frequently asked questions
What is the NADAC price of AMLODIPINE-ATORVAST 10-80 MG?
The current National Average Drug Acquisition Cost (NADAC) for AMLODIPINE-ATORVAST 10-80 MG, manufactured by Dr. Reddy's Laboratories Inc., is $3.2441 per EA (NDC 43598031330), effective Nov 29, 2023.
How has the price of AMLODIPINE-ATORVAST 10-80 MG changed over time?
Over the history we have for it, the NADAC for AMLODIPINE-ATORVAST 10-80 MG has declined 49.2%. It has been tracked across 443 weekly CMS publications since May 14, 2014.
What are the highest and lowest recorded NADAC prices for AMLODIPINE-ATORVAST 10-80 MG?
Since May 14, 2014, the NADAC for AMLODIPINE-ATORVAST 10-80 MG has ranged from a low of $3.2441 (Aug 23, 2023) to a high of $6.9697 (Mar 11, 2015), with a median of $4.1582 per EA.
Are there cheaper alternatives to AMLODIPINE-ATORVAST 10-80 MG?
No other NADAC-published product currently shares the active ingredient and strength of AMLODIPINE-ATORVAST 10-80 MG in a comparable dosage form, so no direct lower-cost alternative is listed.
Who manufactures AMLODIPINE-ATORVAST 10-80 MG?
AMLODIPINE-ATORVAST 10-80 MG (NDC 43598031330) is labeled by Dr. Reddy's Laboratories Inc., and CMS classifies it as a generic product.